Fig. 3
From: Novel bispecific aptamer targeting PD-1 and nucleolin for cancer immunotherapy
Characterization of BiApt. Size distributions of free AS1411 aptamer (A), free PD-1 aptamer (B), and BiApt (C). Zeta potential distribution of BiApt (D)
Fig. 3 | Cancer Nanotechnology